Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 19
Original Research
Clinical Efficacy and Safety of an Immune Checkpoint Inhibitor in Combination with Regorafenib Therapy as Second-Line Regimen for Patients with Unresectable Hepatocellular Carcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,311 | Dovepress* | 3,135+ | 77 | 3,212 | |
| PubMed Central* | 176 | 83 | 259 | ||
| Totals | 3,311 | 160 | 3,471 | ||
| *Since 5 April 2023 | |||||
View citations on PubMed Central and Google Scholar